05/16/2022
5:06 AM | PhaseBio Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/16/2022
5:04 AM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2022
3:13 PM | PhaseBio Pharmaceuticals (Filer)
| Form DEF 14A
| |
09/15/2021
7:15 AM | Humphries William D. (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2021
7:14 AM | Humphries William D. (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/15/2021
7:04 AM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2021
4:52 PM | Mow Jonathan P (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2021
3:24 PM | Hutson Nancy J (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2021
5:07 PM | PhaseBio Pharmaceuticals (Issuer)
Thorp Clay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2021
7:03 AM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
08/10/2021
6:57 AM | PhaseBio Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
07/14/2021
6:06 PM | Arnold Susan Elizabeth (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2021
7:13 AM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2021
5:17 PM | PhaseBio Pharmaceuticals (Issuer)
van den Broek Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2021
5:14 PM | PhaseBio Pharmaceuticals (Issuer)
Sapir Alex (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2021
5:08 PM | HARRIGAN EDMUND (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2021
5:07 PM | Klein Peter Justin (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2021
5:06 PM | Loewy Caroline M (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2021
5:05 PM | Hutson Nancy J (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2021
5:03 PM | PhaseBio Pharmaceuticals (Issuer)
Thorp Clay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2021
5:11 PM | PhaseBio Pharmaceuticals (Issuer)
Sharp John P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2021
5:11 PM | Burkhardt Glen (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2021
5:10 PM | Mow Jonathan P (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2021
5:10 PM | PhaseBio Pharmaceuticals (Issuer)
York Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2021
5:09 PM | Arnold Susan Elizabeth (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2021
5:09 PM | Hanson Kristopher (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2021
1:25 PM | PhaseBio Pharmaceuticals (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G
| |
03/24/2021
3:30 PM | PhaseBio Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G
| |
03/17/2021
4:07 PM | PhaseBio Pharmaceuticals (Filer)
| Form 424B5
| |
03/15/2021
7:42 AM | PhaseBio Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/15/2021
7:18 AM | PhaseBio Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/15/2021
7:10 AM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2021
7:08 AM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2021
3:50 PM | Arnold Susan Elizabeth (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2021
3:48 PM | PhaseBio Pharmaceuticals (Issuer)
Sharp John P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2021
3:45 PM | Lee John Sang (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2021
7:11 AM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2021
3:11 PM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2021
8:10 AM | PhaseBio Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
12/04/2020
2:53 PM | HARRIGAN EDMUND (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/24/2020
3:04 PM | PhaseBio Pharmaceuticals (Issuer)
Thorp Clay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/23/2020
5:43 PM | PhaseBio Pharmaceuticals (Issuer)
Sharp John P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/23/2020
5:42 PM | Hanson Kristopher (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/23/2020
5:40 PM | PhaseBio Pharmaceuticals (Issuer)
York Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/23/2020
5:38 PM | Ballance David James (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/23/2020
5:36 PM | Arnold Susan Elizabeth (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/23/2020
5:34 PM | Mow Jonathan P (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/23/2020
5:27 PM | Burkhardt Glen (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2020
6:19 PM | PhaseBio Pharmaceuticals (Issuer)
Thorp Clay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2020
3:19 PM | PhaseBio Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2020
7:20 AM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2020
7:09 AM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2020
8:08 PM | Arnold Susan Elizabeth (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2020
6:04 PM | Mow Jonathan P (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2020
7:15 PM | PhaseBio Pharmaceuticals (Issuer)
Sharp John P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2020
3:22 PM | PhaseBio Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/11/2020
3:09 PM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2020
3:10 PM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2020
6:02 PM | PhaseBio Pharmaceuticals (Issuer)
Thorp Clay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2020
6:00 PM | Klein Peter Justin (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2020
5:58 PM | PhaseBio Pharmaceuticals (Issuer)
van den Broek Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2020
5:57 PM | Hutson Nancy J (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2020
5:55 PM | HARRIGAN EDMUND (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2020
5:52 PM | Loewy Caroline M (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2020
5:39 PM | PhaseBio Pharmaceuticals (Issuer)
Sapir Alex (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2020
3:36 PM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2020
3:44 PM | PhaseBio Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/30/2020
7:29 AM | PhaseBio Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/30/2020
7:20 AM | PhaseBio Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/30/2020
7:08 AM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2020
5:51 PM | Mow Jonathan P (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2020
5:51 PM | Ballance David James (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2020
5:51 PM | Arnold Susan Elizabeth (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2020
5:50 PM | Lee John Sang (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2020
5:50 PM | PhaseBio Pharmaceuticals (Issuer)
Sapir Alex (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2020
5:50 PM | Hanson Kristopher (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2020
5:49 PM | PhaseBio Pharmaceuticals (Issuer)
Sharp John P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2020
5:49 PM | PhaseBio Pharmaceuticals (Issuer)
York Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2020
5:43 PM | PhaseBio Pharmaceuticals (Issuer)
Sapir Alex (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/14/2020
5:38 PM | Burkhardt Glen (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2020
5:34 PM | Burkhardt Glen (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/14/2020
12:49 PM | PhaseBio Pharmaceuticals (Subject)
Rock Springs Capital Management LP (Filed by)
| Form SC 13G/A
| |
02/11/2020
7:08 AM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2020
3:08 PM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2020
2:36 PM | PhaseBio Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
01/17/2020
12:57 PM | JOHNSON & JOHNSON (Filed by)
PhaseBio Pharmaceuticals (Subject)
| Form SC 13G/A
| |
01/13/2020
3:07 PM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2020
8:07 AM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2020
11:15 PM | PhaseBio Pharmaceuticals (Filer)
| Form EFFECT
| |
12/27/2019
4:28 PM | PhaseBio Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/14/2019
7:16 AM | PhaseBio Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2019
7:16 AM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2019
7:03 AM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2019
6:11 PM | Hanson Kristopher (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2019
6:07 PM | Hanson Kristopher (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2019
3:05 PM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2019
3:10 PM | Mow Jonathan P (Reporting)
PhaseBio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2019
6:42 PM | PhaseBio Pharmaceuticals (Issuer)
Sharp John P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2019
8:06 AM | PhaseBio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2019
8:05 AM | PhaseBio Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
